QIAGEN: Company Profile
QIAGEN, a leading global provider of sample and assay technologies, markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research).
QIAGEN: Company Profile examines the global healthcare company whose sample technologies isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. QIAGEN provides tissue and liquid biopsy-based tests for personalized healthcare using companion diagnostics to guide the use of medicines for treatment of cancer and other diseases.
The company participates in various markets, transforming biological materials into valuable molecular information, covering a broad range of molecular biomarkers and running on PCR, multi-modal and next-generation sequencing platforms.
The report notes agreements and partnerships that have added biomarkers and manufacturing capability to QIAGEN’s pipeline of diagnostics for personalized healthcare applications. Selected acquisitions, which help expand QIAGEN’s test menu, are also outlined.
QIAGEN has had an active 2015. The report discusses recent developments.
The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.